Therapy News and Research

RSS

Targeted alpha therapy offers new hope for treating metastatic melanoma

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body.

12 Mar 2025

Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIV

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for pre-exposure prophylaxis (PrEP).

From Sino Biological Inc. 12 Mar 2025

Gaps in HPV cancer screening and prevention identified for people living with HIV

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.

12 Mar 2025

ADHD prescriptions in England surge by 18% since the pandemic

Prescriptions for attention deficit hyperactivity disorder (ADHD) in England have risen 18% year on year since the pandemic.

12 Mar 2025

Breast cancer deaths expected to fall in the EU and UK by 2025 across most age groups

Death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall mortality rates from the disease are predicted to rise by nearly 10% in 2025.

12 Mar 2025

Natural ingredient gluconolactone offers hope for targeted lupus therapy

Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and damaging organs.

12 Mar 2025

Sent home to heal, patients avoid wait for rehab home beds

After a patch of ice sent Marc Durocher hurtling to the ground, and doctors at UMass Memorial Medical Center repaired the broken hip that resulted, the 75-year-old electrician found himself at a crossroads.

12 Mar 2025

How your gut microbiome shapes anxiety

Researchers examine the role of the gut microbiome in the development of anxiety disorders.

12 Mar 2025

Combining smoking cessation support with NHS Talking Therapies increases quit rates

Research from the University of Bath, funded by Cancer Research UK, published on No Smoking Day 2025, shows that integrating smoking cessation support into NHS Talking Therapies for depression and anxiety increases quit rates.

11 Mar 2025

New mobile app aids in rehabilitating hemiparesis following stroke

Brazilian researchers have developed a cell phone application that helps rehabilitate people who have suffered a stroke.

11 Mar 2025

HSS research highlights faster recovery methods after knee surgery

At this year's American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery (HSS) presented several significant studies, with three focused on new ways to help patients recover faster after total knee arthroplasty (TKA), also known as knee replacement surgery.

11 Mar 2025

Gender gaps in peripheral vascular disease impact diagnosis and treatment

The disparities between men and women in prevalence, risk factors and symptoms of peripheral vascular disease (PVD) have a profound impact on prevention, diagnosis, treatment and outcomes for women, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

11 Mar 2025

Integrated anti-aging strategy could reduce neurodegeneration

Aging significantly impacts neurodegeneration, increasing risks for diseases like Alzheimer's. Research focuses on therapies to enhance cognitive function.

11 Mar 2025

Study reveals the role of transcription factors as therapeutic gateways in MAFLD

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions worldwide. This complex liver disorder ranges from simple steatosis to more severe forms, including metabolic dysfunction-associated steatohepatitis (MASH), which may progress to fibrosis, cirrhosis, and even liver cancer.

11 Mar 2025

Decoding programmed cell death in breast cancer

This review highlights the critical role of ubiquitin-specific proteases (USPs) in regulating programmed cell death (PCD) in breast cancer (BC). As the most prevalent malignant tumor among women, BC remains a significant global health challenge.

11 Mar 2025

Study highlights the role of ELF4 as a key transcription factor in development, immunity, and oncology

ELF4, a transcription factor belonging to the ETS family, has emerged as a pivotal regulator in cell differentiation, immune system function, and cancer progression. This newly published review underscores its molecular complexity and clinical significance, shedding light on its dual role in tumor suppression and oncogenesis.

11 Mar 2025

Study reveals TCM-Based strategies for ferroptosis modulation

Innovative insights into the role of ferroptosis, a unique form of programmed cell death, are reshaping the landscape of disease treatment. This growing field highlights how Traditional Chinese Medicine (TCM) can effectively modulate ferroptosis, offering novel therapeutic approaches for various conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and organ injuries.

11 Mar 2025

Ovarian cancer mutations across populations show similarities and unique differences

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at the University of Utah (the U) and Emory University, revealed that Black women have nearly identical mutations to other previously studied populations.

10 Mar 2025

New test could predict life-threatening side effects of cancer immunotherapy

Medical researchers in Japan have discovered a way to predict a potentially life-threatening side effect of cancer immunotherapy before it occurs.

10 Mar 2025

Platelet-rich plasma may enhance ovarian rejuvenation and improve egg quality in women

A new research paper was published in Aging (Aging-US) on February 18, 2025, Volume 17, Issue 2, titled "Transcriptomic landscape of cumulus cells from patients <38 years old with a history of poor ovarian response (POR) treated with platelet-rich plasma (PRP)."

10 Mar 2025

Therapy News and Research

Targeted alpha therapy offers new hope for treating metastatic melanoma

Gilead’s capsid revolution meets our capsid solutions: Sino Biological – Engineering the tools to outsmart HIV

Gaps in HPV cancer screening and prevention identified for people living with HIV

ADHD prescriptions in England surge by 18% since the pandemic

Breast cancer deaths expected to fall in the EU and UK by 2025 across most age groups

Natural ingredient gluconolactone offers hope for targeted lupus therapy

Sent home to heal, patients avoid wait for rehab home beds

How your gut microbiome shapes anxiety

Combining smoking cessation support with NHS Talking Therapies increases quit rates

New mobile app aids in rehabilitating hemiparesis following stroke

HSS research highlights faster recovery methods after knee surgery

Gender gaps in peripheral vascular disease impact diagnosis and treatment

Integrated anti-aging strategy could reduce neurodegeneration

Study reveals the role of transcription factors as therapeutic gateways in MAFLD

Decoding programmed cell death in breast cancer

Study highlights the role of ELF4 as a key transcription factor in development, immunity, and oncology

Study reveals TCM-Based strategies for ferroptosis modulation

Ovarian cancer mutations across populations show similarities and unique differences

New test could predict life-threatening side effects of cancer immunotherapy

Platelet-rich plasma may enhance ovarian rejuvenation and improve egg quality in women

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News